Alex Buzik is a Partner at WindRose Health Investors and has more than 15 years of experience in healthcare private equity and investment banking. Mr. Buzik is responsible for sourcing, executing and managing healthcare private equity investments at WindRose Health Investors. Prior to joining WindRose Health Investors in 2005, Mr. Buzik worked as a member of the Investment Banking Division at Lehman Brothers, where he focused on mergers and acquisitions as well as capital financings within the healthcare industry. Mr. Buzik currently serves on the board of directors of Accuity Delivery Systems, Kolmac, Ovation Fertility, Traditions Behavioral Health, and TrustHCS. Mr. Buzik formerly served on the board of directors of Aerocare Holdings, Data Driven Delivery Systems, DNA Diagnostics Center, Florida Gulf-to-Bay Anesthesiology, HealthHelp and Woodbury Health Products.
Mr. Buzik received his Masters of Business Administration from The Wharton School at the University of Pennsylvania (majoring in Finance and Health Care Management) and his Bachelor of Arts in Biochemistry from Dartmouth College.
David Pontius is a Principal at WindRose Health Investors. Mr. Pontius received his Bachelor of Science in Business Administration from The University of North Carolina at Chapel Hill. Prior to joining WindRose Health Investors in 2008, Mr. Pontius worked in the Healthcare Investment Banking Group of Oppenheimer & Co. (formerly CIBC World Markets), where he focused on strategic advisory, mergers and acquisitions, and public and private company financings. Mr. Pontius currently serves on the board of directors of Kolmac, MDsave, Ovation Fertility, Shearwater Health, Traditions Behavioral Health, and TrustHCS and is actively involved with WindRose Health Investors’ investment in AGS Health.
Dr. Matt Brubaker is Chief Executive Officer of FMG Leading, an advisory firm that creates organizational transformation by aligning business strategy with human capital performance. He has over 20 years of experience in the field of human capital, with particular expertise in health care and private equity executive leadership development, conflict resolution, pre-acquisition organizational assessment, and post-acquisition culture integration and strategy design. His client list includes a broad range of industry-leading organizations, including Optum, The Children’s Hospital of Philadelphia, Deloitte, CNN, TeamHealth, Massachusetts General Hospital, Hackensack University Medical Center, Turner Broadcasting System, Alliance HealthCare Services, Bristol-Myers Squibb, Chevron, and DaVita. Dr. Brubaker earned his Master of Arts degree in Dispute Resolution at the University of Massachusetts, and his Doctor of Education in Organizational Change (Ed.D.) degree from Pepperdine University’s Graduate School of Education and Psychology. He currently resides in Philadelphia, Pennsylvania with his family.
Michael Hammond has focused on the healthcare services industry for over 35 years. During this time, Mr. Hammond has advised many leading healthcare companies in the development of turnaround and reorganization strategies. Among his many clients, he has completed engagements recently for Catholic Health Initiatives (CO), Cedars-Sinai Medical Center (CA), Children’s Hospital Los Angeles, Geisinger Health System (PA), John Muir Health (CA) Sutter Health (CA), Texas Health Resources, Trinity Health (MI), Virginia Mason Medical Center (WA), and Barnabas Health (NJ).
Prior to the formation of H2C, Mr. Hammond was a founder of Shattuck Hammond Partners Inc. in 1993, a member of the board and management committees, and served as the President and CEO of PricewaterhouseCoopers Securities when Shattuck Hammond was owned by PWC (Shattuck Hammond was sold to Morgan Keegan & Company, Inc. in 2007). Prior to co-founding Shattuck Hammond Partners, Mr. Hammond managed the healthcare investment banking businesses at Salomon Brothers and Morgan Stanley, and was a Principal at Cain Brothers, Shattuck & Company. Prior to joining Salomon Brothers in 1978, Mr. Hammond practiced law at Brown and Wood.
Mr. Hammond currently serves as a board member of Dominion Diagnostic Labs and the boards of various hedge funds sponsored by Graham Capital Management. Previously, he served on the boards of various revenue cycle companies including Accretive Solutions (now R1), Acclara Solutions, Precyse Solutions, and Cymetrix. Furthermore, he served for 17 years on the boards of Danbury Health System and Hospital and was previously the Chairman of the Board of both as well as the Chairman of the Finance Committee. Mr. Hammond also served as a member of the board of the Connecticut Hospital Association. Mr. Hammond received an A.B. degree from Wabash College and a J.D. from Vanderbilt University School of Law.